New York Presbyterian Hospital

Galimedix Therapeutics starts Phase 1 trial of oral GAL-101, an amyloid beta aggregation modulator. Myopia control in 2034 may involve DIMS lenses, developed by Carly Lam. Tenpoint and Visus Therapeutics merge, focusing on presbyopia and cataracts. DOT 0.2 lenses show effectiveness in myopia control. Demodex blepharitis diagnosis and treatment are crucial in dry eye management.

Diagnosing and treating Demodex blepharitis is crucial in dry eye disease management. Demodex infestation prevalence increases with age, affecting over 80% of individuals 60+ years old. Treatment aims to eradicate mites, prevent reinfestation, and alleviate symptoms. FDA-approved lotilaner ophthalmic solution is effective for Demodex infestations.

Dr. Rubinstein to train practitioners on new BOTOX® technique for neck contours in New York. BOTOX® Cosmetic received FDA approval for treating platysma bands, expanding its aesthetic applications.